View Article

  • Implants For Cardiovascular Diseases

  • 1Student of Six Sigma Institute of Technology and Science
    2Principal of Six Sigma Institute of Technology and Science
    3Asst. Professor Six Sigma Institute of Technology and Science
     

Abstract

Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality globally, necessitating continuous advancements in medical interventions. Implantable devices have emerged as promising solutions for managing various aspects of cardiovascular pathologies. This comprehensive review explores the current landscape of innovative implants in the realm of cardiovascular diseases. The review begins by examining the pivotal role of implantable devices in addressing cardiac conditions, ranging from heart failure to arrhythmias. Focus is placed on cardiac rhythm management devices, including pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy devices, highlighting their evolving technologies and clinical applications. Furthermore, the review delves into advancements in the field of cardiovascular stents, discussing novel materials and designs aimed at optimizing vascular patency while minimizing complications. The integration of drug-eluting technologies and bioresorbable materials into stent development is explored, with emphasis on their impact on patient outcomes. The discussion extends to ventricular assist devices (VADs) and total artificial hearts, elucidating their role in providing temporary or long-term mechanical circulatory support. A critical evaluation of challenges and future prospects in enhancing the biocompatibility and durability of these devices is presented. In addition, the review encompasses the burgeoning field of bioelectronic implants, elucidating how neuromodulation devices and bioelectronic medicine are revolutionizing the management of hypertension and heart failure. The integration of smart sensors and closed-loop systems for real-time monitoring and adaptive interventions is discussed in the context of personalized cardiovascular care. Ultimately, this review aims to provide a comprehensive overview of the diverse landscape of cardiovascular implants, offering sights into their evolving technologies, clinical efficacy, and potential avenues for future research and development.The continuous innovation in implantable devices holds great promise for improving the prognosis and quality of life for individuals affected by cardiovascular diseases.

Keywords

Cardiovascular disease, Implants

Reference

  1. Tetali, S., Fricker, A., Van Dom burg, Y., & Roy, I. (2023). Intelligent biomaterials for cardiovascular applications. Current Opinion in Biomedical Engineering, 28, 100474. https://doi.org/10.1016/j.cobme.2023.100474
  2. Qi, P., Maitz, M. F., & Huang, N. (2013). Surface modification of cardiovascular materials and implants. Surface and Coatings Technology, 233, 80–90. Doi: 10.1016/j.surfcoat.2013.02.00
  3. Adhami M, Martin NK, Maguire C, Courtenay AJ, Donnelly RF, Domínguez-Robles J, Larrañeta E. Drug loaded implantable devices to treat cardiovascular disease. Expert Opin Drug Deliv. 2023 Apr;20(4):507-522. Doi: 10.1080/17425247.2023.2190580.
  4. Nangia, R., Singh, H., & Kaur, K. (2016). Prevalence of cardiovascular disease (CVD) risk factors. Medical Journal Armed Forces India, 72(4), 315–319. Doi: 10.1016/j.mjafi.2014.07.007  
  5. Bussooa, A., Neale, S., & Mercer, J. (2018). Future of Smart Cardiovascular Implants. Sensors, 18(7), 2008. doi:10.3390/s18072008
  6. Jung, F., Wischke, C., & Lendlein, A. (2010). Degradable, Multifunctional Cardiovascular Implants: Challenges and Hurdles. MRS Bulletin, 35(08), 607–613. doi:10.1557/mrs2010.529 
  7. Levy, R. J., Johnston, T. P., Sintov, A., & Golomb, G. (1990). Controlled release implants for cardiovascular disease. Journal of Controlled Release, 11(1-3), 245–254. doi:10.1016/0168-3659(90)90137-i
  8. Wischke, C., & Lendlein, A. (2011). Designing multifunctional polymers for cardiovascular implants. Clinical Hemorheology and Microcirculation, 49(1-4), 347–355. doi:10.3233/ch-2011-1485 
  9. Stanis?awska, A... "Biomaterials and Implants in Cardiac and Vascular Surgery - Review" Advances in Materials Science, vol.14, no.3, 2014, pp.5-17. https://doi.org/10.2478/adms-2014-0010
  10. Hermawan, H., Dubé, D., & Mantovani, D. (2010). Degradable metallic biomaterials for cardiovascular applications. Metals for Biomedical Devices, 379–404. doi:10.1533/9781845699246.4.379
  11. Lei, L., Guo, S.-R., Chen, W.-L., Rong, H.-J., & Lu, F. (2011). Stents as a platform for drug delivery. Expert Opinion on Drug Delivery, 8(6), 813–831. doi:10.1517/17425247.2011.572068
  12. Mani, G. (2013). Stent-based drug-delivery systems: current challenges and future trends. Therapeutic Delivery, 4(9), 1079–1082. doi:10.4155/tde.13.63
  13. Merchant, Faisal M., G. William Dec, and Jagmeet P. Singh. "Implantable sensors for heart failure." Circulation: Arrhythmia and Electrophysiology 3, no. 6 (2010): 657-667.
  14. Implantable cardioverter-defibrillators (ICDs) - Mayo Clinic
  15. Implantable Cardioverter Defibrillator (ICD) - Dr Matthew Ginks (oxfordheartdoctor.com)
  16. Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., … Pehrson, S. (2016). Defibrillator Implantation in Patients with Nonischaemic Systolic Heart Failure. New England Journal of Medicine, 375(13), 1221–1230. doi:10.1056/nejmoa1608029  
  17. A. Molloy et al., "Challenges to the Development of the Next Generation of Self-Reporting Cardiovascular Implantable Medical Devices," in IEEE Reviews in Biomedical Engineering, vol. 15, pp. 260-272, 2022, doi: 10.1109/RBME.2021.3110084
  18. Lee, Justin Z., Siva K. Mulpuru, and Win K. Shen. "Leadless pacemaker: performance and complications." Trends in Cardiovascular Medicine 28, no. 2 (2018): 130-141.
  19. Khan, K., Kim, J. A., Gurgu, A., Khawaja, M., Cozma, D., & Chelu, M. G. (2021). Innovations in Cardiac Implantable Electronic Devices. Cardiovascular Drugs and Therapy. doi:10.1007/s10557-021-07163-5 
  20. Sengel, Ceyda Tuba. "Delivery of nanoparticles for the treatment of cardiovascular diseases." Global Journal of Obesity, Diabetes and Metabolic Syndrome 2 (2015): 18-21.
  21. Abraham, William T., and Leor Perl. "Implantable hemodynamic monitoring for heart failure patients." Journal of the American College of Cardiology 70, no. 3 (2017): 389-398.

 

Photo
Komal Bisht
Corresponding author

Student of Six Sigma Institute of Technology and Science

Photo
Vijay Singh
Co-author

Principal of Six Sigma Institute of Technology and Science

Photo
Sushmita Bala
Co-author

Asst. Professor Six Sigma Institute of Technology and Science

Komal Bisht*, Vijay Singh, Sushmita Bala, Implants For Cardiovascular Diseases, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 12, 650-658. https://doi.org/10.5281/zenodo.10428745

More related articles
Evaluation of Antimicrobial Potential and Cytotoxi...
Jisha Kumaran, Ayana N, Namitha R, Adhithya P, Arya K V...
Regulatory Process of Adverse Drug Reporting Case ...
Harshada Gore, Shraddha Ratanwar, Dr. Vijay Navghare, Dr. Surykan...
Parkinson's Disease Beyond Dopamine: Integrating M...
Shubham Turewale, Mahesh Manke, Kiran surwase, Rushikesh choudhar...
Formulation And Development of Herbal Syrup for Anxiety and Stress in Children...
Rameshwar Danave, Dr. Nilesh Chachda, Gaurav Meshram, Vaibhav Zotting...
Stimuli-Responsive Hydrogel: An Overview...
Nityananda Mondal, Sanjiban Utpalkumar Sarkar, Kankana Koner, Arnab Bhunia, Niharika Sarkar, Suvodip...
Antibiotics Used in The Treatment of Diabetic Foot Infections...
Dt. Arifa Begum SK, V Priskilla, Y Srivani, V Tejaswi, S. Dhilip Kumar , Dr A Siva Prasad, Dr K V L ...
Related Articles
A Comprehensive Review on Stability-Indicating RP-HPLC Methods for the Estimatio...
Komal Humbe, Dr. H. Kamble, Sugriv Ghodke, Sonawane A...
Method Development And Method Validation Of Oxycodone And Acetaminophen BY RP-...
Mohammad Irfan Sami, Dr. Iffath Rizwana, Sana Sultana, Wasifa Tabassum, Mirza Osman Baig...
Evaluation of Antimicrobial Potential and Cytotoxicity of Selected Marine Seawee...
Jisha Kumaran, Ayana N, Namitha R, Adhithya P, Arya K V...
More related articles
Evaluation of Antimicrobial Potential and Cytotoxicity of Selected Marine Seawee...
Jisha Kumaran, Ayana N, Namitha R, Adhithya P, Arya K V...
Regulatory Process of Adverse Drug Reporting Case Studies in India...
Harshada Gore, Shraddha Ratanwar, Dr. Vijay Navghare, Dr. Surykant Jadhav...
Parkinson's Disease Beyond Dopamine: Integrating Molecular Pathogenesis, Biomark...
Shubham Turewale, Mahesh Manke, Kiran surwase, Rushikesh choudhari, Dr. Padmaja Giram...
Evaluation of Antimicrobial Potential and Cytotoxicity of Selected Marine Seawee...
Jisha Kumaran, Ayana N, Namitha R, Adhithya P, Arya K V...
Regulatory Process of Adverse Drug Reporting Case Studies in India...
Harshada Gore, Shraddha Ratanwar, Dr. Vijay Navghare, Dr. Surykant Jadhav...
Parkinson's Disease Beyond Dopamine: Integrating Molecular Pathogenesis, Biomark...
Shubham Turewale, Mahesh Manke, Kiran surwase, Rushikesh choudhari, Dr. Padmaja Giram...